Biliary Atresia clinical trials at UCSF

2 in progress, 0 open to eligible people

Showing trials for

  • Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

    Sorry, in progress, not accepting new patients

    Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary atresia who have undergone a Kasai hepatoportoenterostomy.

    San Francisco 5391959, California 5332921 and other locations

  • Database of Infants With Cholestasis

    Sorry, not currently recruiting here

    Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.

    San Francisco 5391959, California 5332921 and other locations

Last updated: